Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MICHAEL D BLASZYK Insider Profile
4 Followers
MICHAEL D BLASZYK, Director at ImmunityBio, holds 265.58K shares in ImmunityBio (Ticker: IBRX), holds 148.78K shares in NantHealth (Ticker: NHIQ). Most recently, MICHAEL D BLASZYK Bought ― shares of ImmunityBio on Jun 05, 2023 for an estimated value of 198.02K.
MICHAEL D BLASZYK has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by MICHAEL D BLASZYK
MICHAEL D BLASZYK's Trading History
ImmunityBio
Jun 05, 2023
Director
Informative Buy
198.02K
$2.10M
NantHealth
Sep 07, 2018
Director
Uninformative Buy
―
$197.88K
List of latest transactions for each holding click on a transaction to see MICHAEL D BLASZYK's performance on stock
You May Also Like
MICHAEL D BLASZYK insider profile FAQ
What is the percentage of profitable transactions made by MICHAEL D BLASZYK?
The percentage of profitable transactions made by MICHAEL D BLASZYK is ―.
What is the average return per transaction made by MICHAEL D BLASZYK?
The average return per transaction made by MICHAEL D BLASZYK is ―.
What stocks does MICHAEL D BLASZYK hold?
MICHAEL D BLASZYK holds: IBRX, NHIQ stocks.
What was MICHAEL D BLASZYK’s latest transaction?
MICHAEL D BLASZYK latest transaction was an Informative Buy of $198.02K.
What was MICHAEL D BLASZYK's most profitable transaction?
MICHAEL D BLASZYK’s most profitable transaction was an Informative Buy of IBRX stock on June 5, 2023. The return on the trade was 227.90%.
What is MICHAEL D BLASZYK's role in ImmunityBio?
MICHAEL D BLASZYK's role in ImmunityBio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.